trending Market Intelligence /marketintelligence/en/news-insights/trending/heyP_FljxCr0ZtNuAZZfvg2 content esgSubNav
In This List

CCM Duopharma Biotech seeks to change name

Blog

Insight Weekly: Ukraine war impact on mining; US bank growth slowdown; cloud computing headwinds

Blog

Insight Weekly: Cryptocurrency's growth; green bond market outlook; coal investors' windfall

Blog

Global M&A By the Numbers: Q1 2022

Blog

Insight Weekly: Challenges for European banks; Japan's IPO slowdown; carmakers' supply woes


CCM Duopharma Biotech seeks to change name

CCM Duopharma Biotech Bhd., a subsidiary of Chemical Co. of Malaysia Bhd., proposed to change its name to Duopharma Biotech Bhd.

The new name was approved and reserved by the Companies Commission of Malaysia. The reservation is valid until March 12, 2019.

The name change is subject to shareholders' approval.

Malaysia-based CCM Duopharma manufactures and distributes pharmaceutical products.